News, Policy & Media

27Aug

New Chairman for MHRA

Stephen Lightfoot has been appointed as the Agency’s new Chair from 1st September 2020. He succeeds Prof Sir Michael Rawlins GBE, Kt who has been the Chair of the Agency Board since December 2014.

Stephen has been a Non-Executive Director of the Agency since September 2015 and is also Deputy Chair of Sussex Community NHS Foundation Trust and Non-Executive Chair of Sussex Primary Care Limited.

Before joining the Board, Stephen had a 30-year career in the life sciences industry working on the development and commercialisation of a wide range of medicines and medical devices in UK and global healthcare companies. His most recent executive roles were General Manager of the global pharmaceutical diagnostics business of GE Healthcare, Managing Director of the UK pharmaceutical business of Daiichi Sankyo and Commercial Director of the UK pharmaceutical and medical device business of Schering Healthcare.

BIVDA will be writing to Stephen when he takes up his position to outline the IVD sector's priorities for the MHRA, especially with regard to regulatory regimes post-December 31st when the transition period ends.

Related

BIVDA enjoyed an excellent day in Parliament as dozens of university researchers exhibited posters e...

Read More >

Public Health England has defended its role in the testing strategy undertaken during the early stag...

Read More >

Aside from the reshuffle, the Government has today announced the Medicines and Medical Devices Bill ...

Read More >

The Government has provided an update on the negotiations between the United Kingdom and New Zealand...

Read More >

Chancellor of the Exchequer Rishi Sunak delivered the Spring Statement to MPs and the public on Wedn...

Read More >

Government has announced that its NHS Test and Trace app will not be launched until winter 2020 and ...

Read More >